findmyKOL

Craig Devoe, MD

Basic profile

Northwell Health

ORCIDNPI
RegionLake Success, NY · NortheastSpecialtyHematology / OncologyFocusOncology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Craig Devoe is an Oncology physician affiliated with Northwell Health. OpenAlex indexes 134 publications with 19,073 citations (h-index 22). By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
134publications

Distinct works indexed by OpenAlex, matched via ORCID.

19,073citations

Total citations across indexed works.

22h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

The Monter Cancer Center
450 Lakeville Road
Lake Success, NY 11042

Telephone

516-734-8973

Registry record last updated 8 Jul 2007.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    43.7%
    Corticosteroid13.1%
    Prednisone100%
    Part D11 patients
    Serotonin-3 Receptor Antagonist12.3%
    Ondansetron Odt100%
    Part D26 patients

    + 4 more classes in this area

  • Cancer & immunology

    22.8%
    Kinase inhibitor11.6%
    Imatinib Mesylate55%Gleevec45%
    Part D<11 patients
    Nucleoside Analog Antiviral11.2%
    Lonsurf100%
    Part D11 patients
  • Cardiovascular

    14.9%
    Loop diuretic9.7%
    Furosemide100%
    Part D<11 patients
    Aldosterone antagonist (MRA)5.2%
    Spironolactone100%
    Part D<11 patients
Where care is delivered (Part B)11.1% facility · 88.9% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”